DYNLRB2

Chr 16

dynein light chain roadblock-type 2

Also known as: DNCL2B, DNLC2B, ROBLD2

Predicted to enable dynein intermediate chain binding activity. Predicted to be involved in microtubule-based movement. Predicted to be located in ciliary tip and male germ cell nucleus. Predicted to be part of cytoplasmic dynein complex. Predicted to be active in centrosome and cytoplasm. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…
0
Active trials
7
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.84
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.84LOEUF
pLI 0.000
Z-score -0.24
OE 1.11 (0.59–1.84)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.92Z-score
OE missense 1.35 (1.12–1.65)
72 obs / 53.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.11 (0.59–1.84)
0≤0.351.4
Missense OE?1.35 (1.12–1.65)
0≤0.61.4
Synonymous OE?1.17
0≤1.21.6
LoF obs/exp: 6 / 5.4Missense obs/exp: 72 / 53.2Syn Z: -0.54

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

DYNLRB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →